Evidence map›Paper›PMID 20212321›Full record

ArticleBiostatistics (Oxford, England)2010

Multiplicity-calibrated Bayesian hypothesis tests.

Mengye Guo, Daniel F Heitjan

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. A Bayesian Spatial Scan Statistic for Multinomial Data.Statistics & probability letters · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mengye GuoDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02446, USA. mengye@jimmy.harvard.edu
Daniel F Heitjan

Funding

TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTERSP50CA084718 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LERMAN, CARYN · 1999 to 2008
$17.8M
BIOBEHAVIORAL LUNG CANCER PREVENTION PROGRAMR01CA063562 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LERMAN, CARYN · 1993 to 2004
$2.7M
TRANSDISCIPLINARY RESEARCH ON GENETICS OF COMPLEX TRAITSP20RR020741 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI KIMMEL, STEPHEN E. · 2004 to 2006
$1.7M
Statistical methods in smoking cessation researchR01CA116723 · NCI · UNIVERSITY OF PENNSYLVANIA · PI HEITJAN, DANIEL FRANCIS · 2007 to 2009
$711k
NCI NIH HHS P50 CA 084718NCI NIH HHS R01 CA 063562NCI NIH HHS R01 CA 116723NCRR NIH HHS P20 RR 020741
6 · The paper itself

Abstract

When testing multiple hypotheses simultaneously, there is a need to adjust the levels of the individual tests to effect control of the family-wise error rate (FWER). Standard frequentist adjustments control the error rate but are typically both conservative and oblivious to prior information. We propose a Bayesian testing approach-multiplicity-calibrated Bayesian hypothesis testing-that sets individual critical values to reflect prior information while controlling the FWER via the Bonferroni inequality. If the prior information is specified correctly, in the sense that those null hypotheses considered most likely to be false in fact are false, the power of our method is substantially greater than that of standard frequentist approaches. We illustrate our method using data from a pharmacogenetic trial and a preclinical cancer study. We demonstrate its error rate control and power advantage by simulation.

Indexed as

Bayes TheoremModels, BiologicalModels, StatisticalResearch DesignBupropionClinical Trials as TopicComputer SimulationDopamine Uptake InhibitorsHumansPolymorphism, Single NucleotideSmoking CessationBupropionDopamine Uptake Inhibitors

Identifiers

PMID20212321
PMCPMC2912702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.